Virusee® SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
(Saliva/Swab)
For diagnostic and professional in vitro applications only
For saliva, nasopharynx and oropharynx swab samples
SARS-CoV-2 Antigen Rapid Test (Colloidal Gold)
(Saliva/Swab)
VSLFA-01/1 test/kit
VSLFA-20/20 tests/kit
The SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) (Saliva/Swab) is a colloidal gold method for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigens in saliva, nasopharyngeal swab and oropharyngeal swab from individuals suspected of having SARS -CoV- exists 2 infection from their healthcare provider.
Positive results indicate the presence of viral antigens, but clinical correlation with history and other diagnostic information is required to determine infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The active ingredient detected may not be the clear cause of the disease. Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for patient treatment decisions, including infection control decisions. Negative results should be considered in the context of a patient's recent exposures, medical history, and presence of clinical signs and symptoms consistent with COVID-19 and, if appropriate, confirmed with a molecular assay for patient management. The SARS-CoV-2 Antigen Rapid Test (Colloidal Gold) (Saliva/Swab) is intended for use by trained clinical laboratory personnel specifically trained and trained in in vitro diagnostic procedures. The test kit only detects the N protein and cannot detect the S protein and its mutation structure. For in vitro diagnostic use only. For professional use only.